Psoriatic Arthritis,
Meet SKYRIZI.

Person using blue phone

SKYRIZI Results

See the data
Person using blue phone

SKYRIZI Dosing

Find out more

SKYRIZI is Now Approved to Treat Psoriatic Arthritis (PsA).

That’s big news for adults with active psoriatic arthritis (PsA), which affects about 30% of people with psoriasis. PsA is inflammation in the joints, fingers, and toes that causes joint pain, stiffness, and swelling. In clinical trials, a majority of people saw a significant improvement in their signs and symptoms. SKYRIZI can help you get back to doing more daily activities.

WITH SKYRIZI,

90% CLEARER SKIN
& SIGNIFICANTLY LESS
JOINT PAIN,
STIFFNESS, &
SWELLING ARE ACHIEVABLE.

With 4 doses a year after 2 starter doses.

The Signs that Point to PsA

When it comes to understanding PsA, we’re here for you! Find out more about what it is and what it isn’t––from symptoms and diagnosis to treatment.

Skyrizi Complete Savings Card

We’re Here for You

With Skyrizi Complete, get the help and
resources you need for your treatment
plan.

Skyrizi Complete offers support, answers to your treatment and insurance questions, and a dedicated Nurse Ambassador* to help you begin and stay on track with your prescribed psoriatic arthritis treatment plan.

*Nurse Ambassadors are provided by AbbVie and do not work under the direction of your health care professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.